Raymond James analyst Christopher Raymond and team sayAbbVie (ABBV) is “not your father’s biotech company” as they initiate coverage with an Outperform rating:
Kevin Hagen for The Wall Street Journal
Initiating coverage of ABBV shares with an Outperform rating and an $82 price target as we think uncertainty over Humira’s intellectual property (IP) creates an....More>>>
European autos shares advanced and U.S. car stocks gained in pre-market trading after China said it will cut the import duty on passenger cars to 15 percent from the current 25 percent. Analysts see positive repercussions for automakers globally, with profits for German carmakers expected to rise.
Europe’s Stoxx 600 Automobiles & Parts Index rose 1.1 percent as of 2:12 p.m. CET,....More>>>
For the first time since I started investing, I have added a stock to my portfolio which is at its all-time high: Broadcom (NASDAQ:AVGO).
AVGO data by YCharts
Broadcom has got some safety issues, but I think they are controllable at the moment. The main reason I have added it to my portfolio is because it is a great combination of a value stock and a growth stock. It has a solid....More>>>
ICICI Direct’s research report on Timken India
Timken India reported strong operational numbers in Q4FY18. Revenues came in strong at | 345.4 crore, up 32.6% YoY. We had estimated 15% topline growth at | 300 crore Absolute EBITDA increased 22.4% YoY to | 46 crore. EBITDA margins came in at 13.3% vs. 14.4% YoY. Lower EBITDA margins were primarily due to a decline in gross margins....More>>>
Since 2012, congressional leaders have pushed to roll back banking regulations in an effort to turbocharge financial growth.
But according to Money Morning Capital Wave Strategist Shah Gilani, Congress has gone too far in its efforts to free up the financial industry.
In fact, there are strong indicators that Congress is actually setting the stage for the next financial crisis.....More>>>
Shares of Jubilant Foodworks touched 52-week high of Rs 2,668, rising over 2 percent intraday Tuesday as company reported strong numbers in the quarter ended March 2018.
It has posted a net profit of Rs 68.1 crore against Rs 6.7 crore in the same quarter of last year. The firm posted stellar growth of 27 percent in its revenues to Rs 780 crore against Rs 612.8 crore year on year.
&l;p&g;As expected, the Federal Reserve increased interest rates for the second time this year, raising the Federal Funds Target rate on June 13, 2018 by 25 basis points (0.25%). This leaves the Fed Funds Target Rate in a range of 1.75% &a;ndash; 2.00%. Their statement following the rate hike announcement was generally positive with the Fed noting they believe the economy is now rising at a &a;ldquo;solid....More>>>
After a disappointing fourth quarter, Exelixis (NASDAQ:EXEL) reaccelerated growth in the first quarter, bolstered by a new approval for Cabometyx in previously untreated advanced renal cell carcinoma (RCC), also known as kidney cancer.
Exelixis results: The raw numbers
John Wiley & Sons Inc (NYSE:JW.A) files its latest 10-K with SEC for the fiscal year ended on April 30, 2018. John Wiley & Sons Inc is a content publisher having its major market in the United States. Among its products are of academic journals, books and online education program management solutions. John Wiley & Sons Inc has a market cap of $3.6 billion; its shares were traded at around....More>>>
Mounting a turnaround effort is always a difficult process, and investors inevitably have to deal with successes and setbacks. Shoe retailer DSW (NYSE:DSW) has had to deal with plenty of turmoil, both because of its own business challenges and due to the tough environment for the retail industry more broadly.
Coming into Wednesday’s fiscal first-quarter financial report, DSW investors....More>>>